Lucien Blondel on Resolve Stroke: To Be Used In the SCULPT Trial
Lucien Blondel, Co-Founder of Quantum Surgical, shared on LinkedIn:
”Resolve Stroke, a French startup developing an ultrasound-based solution to accelerate time to treatment, announced enrollment of first patient in the SCULPT trial.
Over a 6 month period, data will be collected for up to 50 patients of the neuro-intensive care unit at Montpellier University Hospital.
In ICU, patients admitted after brain injuries require daily monitoring.
Traditional X-ray based imaging is the gold standard but has limitations: transporting vulnerable patients, radiation exposure, logistics, etc.
The company led by Aritz Zamacola is betting on advanced software that would transform raw acoustic data into biomarkers.
The SYLVER system enables live imaging of cerebral vasculature and perfusion directly at patient’s bedside.”
Stay updated with Hemostasis Today.
-
Feb 12, 2026, 16:36Tagreed Alkaltham: Tranexamic Acid in PBM
-
Feb 12, 2026, 16:35Paul Lambis Announces Maria Hadjidemetriou as a Speaker at Cyprus Diaspora Forum
-
Feb 12, 2026, 16:34Rahul Bhargava: Breaking Myths About Bone Marrow Transplant
-
Feb 12, 2026, 16:29Arun V J: Can You Be A Doctor And Still Be Stupid?
-
Feb 12, 2026, 16:26Changing the Narrative Around PPH – End Postpartum Hemorrhage
-
Feb 12, 2026, 16:20Mahesan Subramaniam: The Protective Switch in Brain Immune Cells Could Slow Alzheimer’s Disease
-
Feb 12, 2026, 16:13Lale Tokgözoğlu: Top 10 Dyslipidemia Papers of 2025
-
Feb 12, 2026, 16:10Neelam Mohan: Breaking Down Anemia from Causes and Testing to Treatment and Prevention
-
Feb 12, 2026, 16:04Irma Bagdoniene: From Estimating Risk to Seeing Disease in Preventive Cardiology